RNASEH2C
Basic information
Region (hg38): 11:65714005-65720818
Links
Phenotypes
GenCC
Source:
- Aicardi-Goutieres syndrome 3 (Definitive), mode of inheritance: AR
- Aicardi-Goutieres syndrome 3 (Strong), mode of inheritance: AR
- Aicardi-Goutieres syndrome 3 (Strong), mode of inheritance: AR
- Aicardi-Goutieres syndrome (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Aicardi-Goutieres syndrome 3 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Cardiovascular; Gastrointestinal; Dermatologic; Hematologic; Neurologic | 16845400; 17846997; 20301648; 23322642 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNASEH2C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 91 | 94 | ||||
missense | 109 | 113 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 5 | 13 | 18 | |||
non coding | 47 | 61 | 115 | |||
Total | 0 | 5 | 168 | 154 | 9 |
Variants in RNASEH2C
This is a list of pathogenic ClinVar variants found in the RNASEH2C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-65714512-T-C | Likely benign (Oct 01, 2022) | |||
11-65714532-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
11-65714726-T-A | Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities | Uncertain significance (Aug 25, 2022) | ||
11-65714734-G-C | not specified • Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities | Uncertain significance (Aug 18, 2023) | ||
11-65716773-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
11-65716888-GGAGA-G | Uncertain significance (Jun 01, 2024) | |||
11-65716901-A-G | KAT5-related disorder | Uncertain significance (May 10, 2024) | ||
11-65716922-T-A | Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities | Pathogenic (Dec 04, 2020) | ||
11-65716981-CAGTG-C | Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities | Uncertain significance (Jun 29, 2021) | ||
11-65717686-G-A | Aicardi-Goutieres syndrome 3 | Benign (Jan 13, 2018) | ||
11-65717747-G-A | Aicardi-Goutieres syndrome 3 | Benign (Jan 12, 2018) | ||
11-65717806-G-A | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65717866-A-G | Aicardi-Goutieres syndrome 3 | Benign (Jan 12, 2018) | ||
11-65717952-C-T | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65717977-C-T | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 12, 2018) | ||
11-65718005-G-C | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65718007-G-A | Aicardi-Goutieres syndrome 3 | Benign (Jan 13, 2018) | ||
11-65718015-G-A | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65718046-G-A | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65718084-C-G | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65718125-C-G | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65718162-T-C | Aicardi-Goutieres syndrome 3 | Benign (Jan 13, 2018) | ||
11-65718189-C-T | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 13, 2018) | ||
11-65718251-C-T | Aicardi-Goutieres syndrome 3 | Uncertain significance (Jan 12, 2018) | ||
11-65718256-T-G | Aicardi-Goutieres syndrome 3 | Benign (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNASEH2C | protein_coding | protein_coding | ENST00000308418 | 4 | 6052 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00550 | 0.732 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.917 | 122 | 96.6 | 1.26 | 0.00000463 | 1037 |
Missense in Polyphen | 38 | 34.385 | 1.1051 | 370 | ||
Synonymous | -1.41 | 54 | 42.3 | 1.28 | 0.00000219 | 356 |
Loss of Function | 0.791 | 4 | 6.11 | 0.655 | 2.73e-7 | 69 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000153 | 0.000153 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000598 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000634 | 0.0000615 |
Middle Eastern | 0.0000598 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Non catalytic subunit of RNase H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging- strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:16845400, ECO:0000269|PubMed:21177858}.;
- Pathway
- DNA replication - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.277
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.39
Haploinsufficiency Scores
- pHI
- 0.0824
- hipred
- N
- hipred_score
- 0.296
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.910
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnaseh2c
- Phenotype
- growth/size/body region phenotype; embryo phenotype; skeleton phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype;
Gene ontology
- Biological process
- RNA catabolic process
- Cellular component
- nucleus;ribonuclease H2 complex
- Molecular function